The first step in the transport of cyanocobalamin (CN-B12) by cells of Escherichia coli was shown previously to consist of binding of the B12 to specific receptor sites located on the outer membrane of the cell envelope. In this paper, evidence is presented that these B12 receptor sites also function as the receptors for the E colicins, and that there is competition between B12 and the E colicins for occupancy of these sites. The cell strains used were E. coli KBTOO1, a methionine/B12 auxotroph, and B12 transport mutants derived from strain KBTOO1. Colicins El and E3 inhibited binding of B12 to the outer membrane B12 receptor sites, and CN-B12 protected cells against these colicins. Half-maximal protection was given by CN-B12 concentrations in the range of 1 to 6 nM, depending upon the colicin concentration used. Colicin El competitively inhibited the binding of 57Co-labeled CN-B12 to isolated outer membrane particles. Functional colicin E receptor sites were found in cell envelopes from cells of only those strains that possessed intact B12 receptors. Colicin K did not inhibit the binding of B12 to the outer membrane receptor sites, and no evidence was found for any identity between the B12 and colicin K receptors. However, both colicin K and colicin El inhibited the secondary phase of B12 transport, which is believed to consist of the energy-coupled movement of B12 across the inner membrane.
The first step in the transport of cyanocobalamin (CN-B12) by cells of Escherichia coli was shown previously to consist of binding of the B12 to specific receptor sites located on the outer membrane of the cell envelope. In this paper, evidence is presented that these B12 receptor sites also function as the receptors for the E colicins, and that there is competition between B12 and the E colicins for occupancy of these sites. The cell strains used were E. coli KBTOO1, a methionine/B12 auxotroph, and B12 transport mutants derived from strain KBTOO1. Colicins El and E3 inhibited binding of B12 to the outer membrane B12 receptor sites, and CN-B12 protected cells against these colicins. Half-maximal protection was given by CN-B12 concentrations in the range of 1 to 6 nM, depending upon the colicin concentration used. Colicin El competitively inhibited the binding of 57Co-labeled CN-B12 to isolated outer membrane particles. Functional colicin E receptor sites were found in cell envelopes from cells of only those strains that possessed intact B12 receptors. Colicin K did not inhibit the binding of B12 to the outer membrane receptor sites, and no evidence was found for any identity between the B12 and colicin K receptors. However, both colicin K and colicin El inhibited the secondary phase of B12 transport, which is believed to consist of the energy-coupled movement of B12 across the inner membrane.
We have shown previously that the uptake of vitamin B12 by Escherichia coli consists of a rapid, initial phase followed by a slower, secondary phase (4, 5) . The initial phase of uptake consists of binding of vitamin B12 to specific receptors which are firmly bound to the outer membrane of the cell envelope (14) . The subsequent steps required to transfer the B12 from these receptors and move it across the inner membrane and into the interior of the cell constitute the secondary phase of uptake. At least one of these secondary steps is coupled to the energy metabolism of the cell. During the course of studies on the energy coupling processes involved in this transport system, the effects of colicin El upon B12 uptake were investigated. It has been shown in other laboratories that colicin El can inhibit some energycoupled transport systems in E. coli (1, 6) . In our work, it quickly became apparent that colicin El, in addition to inhibiting the secondary phase of B12 transport, inactivated the initial B12 binding sites. We have followed up this observation and have obtained evidence that the outer membrane receptor sites for vitamin B12 also serve as the receptor sites for the E colicins. These results are presented in this paper. Kadner sham/Searle Corp., Arlington Heights, Ill. L-proline-U-'4C (200 mCi/mmol) and L-lysine-U-"C (210 mCi/ mmol) came from ICN, Irvine, Calif., and Schwarz/ Mann, Orangeburg, N.Y., supplied the L-leucine-U-4C (312 mCi/mmol).
Organisms. The bacterial strains used in this work were E. coli KBT001, a methionine/B,2 auxotroph of genotype F-(leu, pro, lysA, trp, purE, metE, str, lac), and B,2 transport mutants derived from this strain.
These strains have been described more fully previously (5, 15) and are listed in Table 1 . Their genetic properties are presented in the accompanying paper (9) . The cells were maintained on nutrient agar and, for experimental purposes, were grown on the minimal medium of Davis and Mingioli (3) supplemented with 0.5% glucose, adenine (40 pg/ml), and the required amino acids (50 Ag/ml).
Colicin preparation. Colicins El, E3 and K were prepared from cells of E. coli strains ML(COL El+), CA38, and K235, respectively. The methods followed those described by Herschman and Helinski (8) for colicin E3, and included induction with mitomycin C (0.2 Mg/ml), extraction of the cells with 1 M NaCl, and collection of the protein which precipitated between 15 and 50% saturated ammonium sulfate. The colicins were dissolved and diluted in colicin diluent, which was filter sterilized and which contained bovine serum albumin (2 mg/ml), 0.85% NaCl, 5 mM MgCl2, and 0.5 mM CaClI.
Colicin assays. The colicins were assayed routinely by means of a plate assay (10) . Plates of nutrient agar (containing 50 gg of streptomycin per ml) were overlaid with 0.7% nutrient agar (3 ml) containing about 108 cells from a sensitive strain of E. coli (usually KBT001). Samples (10 Mliters) of 10-fold dilutions of the colicins were placed on the soft agar, and the plates were incubated overnight. The reciprocal of the highest dilution which gave a distinct inhibition of growth was used as a measure of the colicin titer.
Assay of CN-B12 uptake. The methods used to measure uptake of CN-B,2 by whole cells of E. coli Assay of protein synthesis. In addition to the plate assay method, the activity of colicin E3 was also determined by measuring its ability to inhibit protein synthesis in cells of E. coli. Overnight cultures of an appropriate strain (usually KBT001) were used to inoculate final cultures in the minimal medium described above which was further supplemented with yeast extract (0.5 mg/ml). These cultures were grown to mid-log phase, then samples (5 ml) were transferred to small flasks in a water bath shaker at 37 C. After 10 min various amounts of colicin E3 were added and, after a further 10 min of incubation, 1 ml of the growth medium containing 0.25 ,uCi of L-_[4C]leucine was added to each flask. Shaking was continued for 10 min, and protein synthesis was stopped by pouring the samples into iced tubes which contained 0.5 mg of chloramphenicol in 0.5 ml of water. The samples were mixed and allowed to stand in ice for several minutes. Duplicate 2.5-ml samples were taken from each tube, added to 2.5 ml of 10% trichloroacetic acid, and incubated in boiling water for 20 min. The precipitated protein was collected on glass fiber filters (2.5 cm), which were then washed twice with 10 ml of 5% trichloroacetic acid (containing 0.2 mg of L-leucine per ml) and once with 10 ml of 95% ethanol. The filters were dried and counted in a liquid scintillation counter. Control experiments (experiments without colicin E3) showed that the incorporation of "C into precipitable protein was linear with time for about 20 min in this system.
Isolation of cell envelope particles from E. coli cells. These methods have been described previously (11, 14) . Cells of the desired E. coli strain, from 1 liter of a late log-phase culture, were suspended in 200 ml of 0.05 M tris(hydroxymethyl)aminomethane-hydrochloride buffer at pH 7.8, containing 1 mM ethylenediaminetetraacetic acid, and were mixed in a Sorvall Omnimixer. The cells were recovered by centrifugation at 0 C and were resuspended in 50 ml of the same buffer. After addition of about 1 mg each of pancreatic ribonuclease and deoxyribonuclease, the suspension was passed twice through an Aminco French pressure cell at 20,000 lbs/in2. Magnesium chloride was added to give a final concentration of 2 mM, and any intact cells were removed by centrifugation at 3,000 x g for 5 min and at 6,000 x g for 7 min. The cell envelope particles were sedimented by centrifugation for 1 h at 2 C and 144,000 x g. Outer membrane particles were derived from these whole envelope preparations by selective solubilization of the inner membranes by using 10 mM KPO4, pH 6.6, containing 2% Triton X-100 and 1 mM MgCl2, and recentrion June 26, 2017 by guest http://jb.asm.org/ Downloaded from fugation at 144,000 x g for 60 min, as described by Schnaitman (12) .
Other methods. Protein was determined primarily by the method of Waddell (13) . RESULTS Effects of colicins El, E3, and K upon the uptake of CN-B,2. Figure 1 shows the effects of various amounts of colicin El upon the uptake of 57Co-CN-B12 by whole cells of E. coli KBT001. In the absence of the colicin the normal biphasic pattern of B12 uptake was observed, which consisted of a rapid initial phase which was complete within the first minute, followed by a slower, secondary phase which was linear for about 30 min. The Essentially the same results were obtained when other, more specific assays of colicin action were made. Figure 2 shows the effects of colicin E3 upon incorporation of L-["C]leucine into protein by whole cells of three E. coli strains. No inhibition was obtained with cells of strain KBT026, which lack outer membrane B 12 receptors. Similarly, Fig. 3 shows the effects of colicin El upon the uptake of L-[4C ]proline by cells of strains KBT041 and KBT026. Again, there was no effect upon cells of strain KBT026. The uptake of proline was inhibited in cells of strain KBT041, but complete protection against the colicin El was obtained by inclusion of 1 MM CN-B,, in the reaction mixture.
Vitamin B12 was unable to protect cells from the action of colicin K. Colicin K inhibited the uptake of L-[14C Ilysine by cells of strain KBTOO1, but CN-B12 had no detectable effect upon this inhibition (Fig. 4) .
Assay of colicin receptors in cell envelopes from E. coli strains KBTOOI, KBT026, KBT041, and KBT069. The presence of colicin receptors in cell envelopes of the various E. coli strains was assayed by measuring the ability of such envelope preparations to neutralize the colicins. Tenfold dilutions of the colicins were incubated with cell envelope particles for 15 min at 37 C prior to assay by the plate tech-nique (Table 4) . Neutralization of the E colicins occurred with cell envelopes only from those strains which possessed functional B12 receptor sites on the outer membrane (i.e., KBT001 and KBT041, but not KBT026 or KBT069).
The neutralization of colicins El and K is also shown in Fig. 5 . In these experiments, the envelope particles were removed by centrifugation (144,000 x g at 2 C for 30 min) after neutralization at 37 C, and the colicin content of the supernatant solutions was assayed by measuring their ability to inhibit the uptake of L-["4C]lysine by cells of E. coli KBTO01. Cell envelopes from strain KBT026, which lack the outer membrane B12 binding sites, were again shown to lack functional receptors for colicin El. All of the strains tested possessed cell envelopes which were able to neutralize colicin K.
Interactions of vitamin B12 with the colicin systems. The ability of CN-B12 to protect sensitive cells against the action of the E colicins has been studied. Inhibition of lysine uptake was used as an index of colicin El >3- activity. The amount of colicin El used was that which gave about 70% inhibition of the rate of lysine uptake by cells of E. coli KBT041. This strain was selected because it has no secondary phase of B12 uptake, and the B,2 taken up remains associated with the cell surface. The degree of protection conferred by varying levels of CN-B,2 against colicin El in this system was concentration in the reaction mixtures. The rate of lysine uptake in the presence of colicin El and without any B12 was 0%, and the rate of lysine uptake in the absence of the colicin was 100%o. The inset (Fig. 6) shows a double reciprocal plot of the same data, and an apparent K. for CN-B,2 of about 1 nM was obtained. This value is only slightly above that which was previously determined for the B12 receptor sites (14) .
In a similar experiment the effects of the CN-B12 concentration upon colicin E3 activity were studied. Inhibition of the rate of protein synthesis by cells of E. coli KBT001 was used as a measure of colicin E3 activity. In Fig. 7 the percentage of protection against colicin E3 is plotted against the concentration of CN-B,2. Half-maximal protection was given by about 6 nM CN-B,2.
Further evidence for the interaction of vita- min B12 and colicin El at the same outer membrane sites is presented in Fig. 8 . In this experiment the effects of colicin El upon the binding of "7Co-CN-B,2 to outer membrane particles from E. coli KBT001 were measured at 0 C, by using the membrane filtration assay. The concentrations of colicin El and of CN-B,2 were both varied. The lines of best fit in the double reciprocal plot (inset, Fig. 8 (1, 6) .
In the experimental work described in this paper, we were initially interested in determining whether colicins El and K inhibited the energy-dependent phase of B12 transport in E. coli. Colicin El was found to inhibit the energycoupled secondary phase of B12 uptake (Fig. 1) (Fig. 8) . The same correlations between sensitivity to the E colicins and the presence of functional B12 receptors were also observed in experiments which measured the inhibition of amino acid uptake by colicin El, and the inhibition of protein synthesis by colicin E3. There was no correlation between the presence of B12 receptors and sensitivity of cells to colicin K, although colicin K did inhibit the energy-coupled secondary phase of B12 transport. The results of some control experiments, in which we were unable to detect any direct interaction between vitamin B12 and the E colicins, are consistent with our view that B12 and these colicins interact via competition for common receptor sites. Thus CN-B12 did not inactivate colicins El and E3, and these colicins did not bind 57Co-CN-B12 (data not shown).
Although vitamin B12 and the E colicins use the same outer membrane receptors, it seems likely that they do not share a common system for crossing or interacting with the inner membrane. This conclusion is based on the observation that cells of E. coli KBT041 (a strain which lacks the energy-coupled secondary phase of B12 transport but possesses functional outer membrane B12 binding sites) are sensitive to colicins El and E3.
The colicin E receptors on the E. coli cell envelope apparently also serve as receptor sites for the bacteriophage BF23 (2, 7) . It might be expected, therefore, that vitamin B12 would protect sensitive cells against this bacteriophage, but we have not yet investigated this possibility. The utilization of the same receptor sites by vitamin B12, bacteriophage BF23, and the E colicins does not necessarily mean that all of the components of these receptors are shared. Sabet and Schnaitman (lOa) have obtained some evidence which indicates that the colicin El receptors require some additional constituent which is not required by the E3 receptors.
The possession of B12 receptors in the outer membrane of the E. coli cell envelope evidently confers a physiological advantage upon these cells, whereas colicin receptors per se are clearly potentially dangerous. The association of these disparate functions within a single structural element offers a possible rationale for the evolutionary retention of the disadvantageous component. It will be of interest to see whether the receptors for other colicins and other bacteriophages are necessary components of some other physiologically advantageous systems.
